Cantwell Mark Joseph 4
4 · ADVENTRX PHARMACEUTICALS INC · Filed Jan 17, 2007
Insider Transaction Report
Form 4
Cantwell Mark Joseph
VP, Research & Development
Transactions
- Award
Stock Option (Right to Buy)
2007-01-12+25,000→ 25,000 totalExercise: $2.75Exp: 2017-01-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]1/4 of the total shares subject to the option vest and become exercisable on January 1, 2008, which is the first anniversary of the vesting commencement date; 1/48 of the total shares subject to the option vest and become exercisable at the end of each successive month thereafter.